Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin

Molecular Psychiatry

Volumn 20, Issue 3, 2015, Pages 388-397

  Durak, O ^a   De Anda, F C ^a,e   Singh, K K ^a,f   Leussis, M P ^a,b,c,g   Petryshen, T L ^a,b,c   Sklar, P ^d   Tsai, L H ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f MCMASTER UNIVERSITY   (Canada)

^g EMMANUEL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANKYRIN G; BETA CATENIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; ACTIN; ANK3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WNT SIGNALING PATHWAY; ANIMAL; CARCINOMA; CELL CULTURE; CELL FRACTIONATION; CYTOLOGY; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; MAMMALIAN EMBRYO; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PREGNANCY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ACTINS; ANIMALS; ANKYRINS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, TRANSGENIC; NEUROGENESIS; NEURONS; PREGNANCY; SUBCELLULAR FRACTIONS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84924744563     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.42     Document Type: Article

References (48)

1. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237-241
2. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543
3. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678
4. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, et al. A genomewide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2007; 13: 197-207
5. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008; 13: 558-569
6. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-1058
7. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, et al. Genomewide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009; 14: 755-763
8. Pandey A, Davis NA, White BC, Pajewski NM, Savitz J, Drevets WC, et al. Epistasis network centrality analysis yields pathway replication across two GWAS cohorts for bipolar disorder. Transl Psychiatry 2012; 2: e154
9. Hatzimanolis A, Smyrnis N, Avramopoulos D, Stefanis CN, Evdokimidis I, Stefanis NC. Bipolar disorder ANK3 risk variant effect on sustained attention is replicated in a large healthy population. Psychiatr Genet 2012; 22: 210-213
10. Linke J, Witt SH, King AV, Nieratschker V, Poupon C, Gass A, et al. Genome-wide supported risk variant for bipolar disorder alters anatomical connectivity in the human brain. NeuroImage 2012; 59: 3288-3296
11. Roussos P, Katsel P, Davis KL, Bitsios P, Giakoumaki SG, Jogia J, et al. MOlecular and genetic evidence for abnormalities in the nodes of ranvier in schizophrenia. Arch Gen Psychiatry 2012; 69: 7-15
12. Bi C, Wu J, Jiang T, Liu Q, Cai W, Yu P, et al. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Hum Mutat 2012; 33: 1635-1638
13. Iqbal Z, Vandeweyer G, van der Voet M, Waryah AM, Zahoor MY, Besseling JA, et al. Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. Hum Mol Genet 2013; 22: 1960-1970
14. Shi L, Zhang X, Golhar R, Otieno FG, He M, Hou C, et al. Whole-genome sequencing in an autism multiplex family. Mol Autism 2013; 4: 8
15. Kordeli E, Lambert S, Bennett V. Ankyrin. J Biol Chem 1995; 270: 2352-2359
16. Grubb MS, Burrone J. Building and maintaining the axon initial segment. Curr Opin Neurobiol 2010; 20: 481-488
17. Hedstrom KL, Ogawa Y, Rasband MN. AnkyrinG is req uired for maintenance of the axon initial segment and neuronal polarity. J Cell Biol 2008; 183: 635-640
18. Sobotzik JM, Sie JM, Politi C, Del Turco D, Bennett V, Deller T, et al. AnkyrinG is required to maintain axo-dendritic polarity in vivo. Proc Natl Acad Sci USA 2009; 106: 17564-17569
19. Kizhatil K, Davis JQ, Davis L, Hoffman J, Hogan BL, Bennett V. Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. J Biol Chem 2007; 282: 26552-26561
20. Chenn A, Walsh CA. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002; 297: 365-369
21. Woodhead GJ, Mutch CA, Olson EC, Chenn A. Cell-Autonomous beta-catenin signaling regulates cortical precursor proliferation. J Neurosci 2006; 26: 12620-12630
22. Zhou C-J, Zhao C, Pleasure SJ. Wnt signaling mutants have decreased dentate granule cell production and radial glial scaffolding abnormalities. J Neurosci 2004; 24: 121-126
23. Kim WY, Wang X, Wu Y, Doble BW, Patel S, Woodgett JR, et al. GSK-3 is a master regulator of neural progenitor homeostasis. Nat Neurosci 2009; 12: 1390-1397
24. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246-250
25. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012; 149: 525-537
26. Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK, et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009; 136: 1017-1031
27. Duan X, Chang JH, Ge S, Faulkner RL, Kim JY, Kitabatake Y, et al. Disrupted-inschizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007; 130: 1146-1158
28. Singh KK, Ge X, Mao Y, Drane L, Meletis K, Samuels BA, et al. Dixdc1 is a critical regulator of DISC1 and embryonic cortical development. Neuron 2010; 67: 33-48
29. Wexler EM, Geschwind DH. DISC1: A Schizophrenia Gene with Multiple Personalities. Neuron 2011; 72: 501-503
30. Buchman JJ, Durak O, Tsai LH. ASPM regulates Wnt signaling pathway activity in the developing brain. Genes Dev 2011; 25: 1909-1914
31. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004; 303: 1483-1487
32. Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harbor Perspect Biol 2010; 2: a002915
33. Yu X, Malenka RC. [Beta]-catenin is critical for dendritic morphogenesis. Nat Neurosci 2003; 6: 1169-1177
34. Noles SR, Chenn A. Cadherin inhibition of beta-catenin signaling regulates the proliferation and differentiation of neural precursor cells. Mol Cell Neurosci 2007; 35: 549-558
35. Leussis MP, Berry-Scott EM, Saito M, Jhuang H, de Haan G, Alkan O, et al. The ANK3 bipolar disorder gene regulates psychiatric-related behaviors that are modulated by lithium and stress. Biol Psychiatry 2013; 73: 683-690
36. Zhou D, Lambert S, Malen PL, Carpenter S, Boland LM, Bennett V. AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J Cell Biol 1998; 143: 1295-1304
37. Xie Z, Moy LY, Sanada K, Zhou Y, Buchman JJ, Tsai LH. Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. Neuron 2007; 56: 79-93
38. Dehay C, Kennedy H. Cell-cycle control and cortical development. Nat Rev Neurosci 2007; 8: 438-450
39. Bultje RS, Castaneda-Castellanos DR, Jan LY, Jan YN, Kriegstein AR, Shi SH. Mammalian Par3 regulates progenitor cell asymmetric division via notch signaling in the developing neocortex. Neuron 2009; 63: 189-202
40. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, et al. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86: 391-399
41. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 1997; 88: 789-799
42. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 1999; 112: 1237-1245
43. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. [Beta]-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997; 16: 3797-3804
44. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, et al. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr Biol 1999; 9: 207-211
45. Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009; 35: 528-548
46. Insel TR. Rethinking schizophrenia. Nature 2010; 468: 187-193
47. Paez-Gonzalez P, Abdi K, Luciano D, Liu Y, Soriano-Navarro M, Rawlins E, et al. Ank3-dependent SVZ niche assembly is required for the continued production of new neurons. Neuron 2011; 71: 61-75
48. Gould TD, Manji HK. The Wnt signaling pathway in bipolar disorder. Neuroscientist 2002; 8: 497-511